BGI Genomics Co Ltd (300676) - Total Liabilities

Latest as of March 2026: CN¥2.81 Billion CNY ≈ $410.62 Million USD

Based on the latest financial reports, BGI Genomics Co Ltd (300676) has total liabilities worth CN¥2.81 Billion CNY (≈ $410.62 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BGI Genomics Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

BGI Genomics Co Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how BGI Genomics Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 300676 total asset value.

BGI Genomics Co Ltd Competitors by Total Liabilities

The table below lists competitors of BGI Genomics Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Resideo Technologies Inc NYSE:REZI	USA	$5.29 Billion
Plug Power Inc NASDAQ:PLUG	USA	$1.61 Billion
JOYY Inc NASDAQ:JOYY	USA	$898.33 Million
Dialog Group Bhd KLSE:7277	Malaysia	RM3.50 Billion
Sichuan Qiaoyuan Gas Co.Ltd SHE:301286	China	CN¥199.82 Million
Soleno Therapeutics Inc NASDAQ:SLNO	USA	$112.59 Million
Steadfast Group Limited F:1S6	Germany	€3.80 Billion
Transmissora Aliança de Energia Elétrica S.A SA:TAEE11	Brazil	R$14.17 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down BGI Genomics Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BGI Genomics Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BGI Genomics Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BGI Genomics Co Ltd (2012–2025)

The table below shows the annual total liabilities of BGI Genomics Co Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥3.14 Billion ≈ $459.70 Million	-3.95%
2024-12-31	CN¥3.27 Billion ≈ $478.60 Million	-9.37%
2023-12-31	CN¥3.61 Billion ≈ $528.11 Million	-13.32%
2022-12-31	CN¥4.16 Billion ≈ $609.28 Million	-13.49%
2021-12-31	CN¥4.81 Billion ≈ $704.26 Million	-9.60%
2020-12-31	CN¥5.32 Billion ≈ $779.04 Million	+251.02%
2019-12-31	CN¥1.52 Billion ≈ $221.94 Million	+51.36%
2018-12-31	CN¥1.00 Billion ≈ $146.62 Million	+17.35%
2017-12-31	CN¥853.88 Million ≈ $124.95 Million	+9.82%
2016-12-31	CN¥777.52 Million ≈ $113.78 Million	+4.88%
2015-12-31	CN¥741.37 Million ≈ $108.49 Million	+27.08%
2014-12-31	CN¥583.40 Million ≈ $85.37 Million	-35.14%
2013-12-31	CN¥899.46 Million ≈ $131.62 Million	+5.41%
2012-12-31	CN¥853.31 Million ≈ $124.87 Million	--

About BGI Genomics Co Ltd

SHE:300676 China Diagnostics & Research

Market Cap

$2.76 Billion

CN¥18.87 Billion CNY

Market Cap Rank

#5165 Global

#901 in China

Share Price

CN¥45.12

Change (1 day)

+2.50%

52-Week Range

CN¥32.88 - CN¥59.25

All Time High

CN¥248.01